Literature DB >> 19047312

Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion.

G-N Liu1, H-Z Shi, Z-H Xie, H-H Shen, H-Q Huang, J-M Deng, Q-L Liang, Y-B Wu.   

Abstract

The aim of this study was to investigate the presence of epithelial neutrophil-activating peptide (ENA)-78 in pleural effusions, as well as the chemoattractant activity of pleural ENA-78 on neutrophils. Pleural effusion and serum samples were collected from 75 patients who presented to the respiratory institute (19 with malignant pleural effusion, 21 with tuberculous pleural effusion, 18 with infectious pleural effusion and 17 with transudative pleural effusion). The concentrations of ENA-78, myeloperoxidase and neutrophil elastase were determined, and the chemoattractant activity of ENA-78 for neutrophils both in vitro and in vivo was also observed. The concentrations of ENA-78, myeloperoxidase and neutrophil elastase in infectious pleural effusion were significantly higher than those in malignant, tuberculous and transudative groups, respectively (all p<0.01). Infectious pleural fluid was chemotactic for neutrophils in vitro and anti-ENA-78 antibody could partly inhibit these chemotactic effects. Intrapleural administration of ENA-78 produced a marked progressive influx of neutrophils into pleural space. Compared with noninfectious pleural effusion, ENA-78 appeared to be increased in infectious pleural effusion. Our data suggested that ENA-78 was able to induce neutrophil infiltration into pleural space and might be responsible for pleural neutrophil degranulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047312     DOI: 10.1183/09031936.00111908

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.

Authors:  Zhi-Jian Ye; Qiong Zhou; Rong-Hui Du; Xiao Li; Bo Huang; Huan-Zhong Shi
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 2.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

3.  Influence of Malignant Pleural Fluid from Lung Adenocarcinoma Patients on Neutrophil Response.

Authors:  Maria Mulet; Rubén Osuna-Gómez; Carlos Zamora; José M Porcel; Juan C Nieto; Lídia Perea; Virginia Pajares; Ana M Muñoz-Fernandez; Nuria Calvo; Maria Alba Sorolla; Silvia Vidal
Journal:  Cancers (Basel)       Date:  2022-05-20       Impact factor: 6.575

4.  Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.

Authors:  Amanda J Stolarz; Ryan A Farris; Charla A Wiley; Catherine E O'Brien; Elvin T Price
Journal:  Clin Transl Sci       Date:  2015-08-10       Impact factor: 4.689

5.  Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.

Authors:  Ya-Lan Liu; Yan-Bing Wu; Kan Zhai; Xiao-Juan Wang; Huan-Zhong Shi
Journal:  Sci Rep       Date:  2016-01-19       Impact factor: 4.379

Review 6.  Peptide-based materials for cancer immunotherapy.

Authors:  Lu Zhang; Yanyu Huang; Aaron Raymond Lindstrom; Tzu-Yin Lin; Kit S Lam; Yuanpei Li
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

7.  Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.

Authors:  Chia-Yu Yang; Yu-Hsuan Kuo; Min Chen; Chih-Liang Wang; Li-Jane Shih; Yu-Ching Liu; Pei-Chun Hsueh; Yi-Hsuan Lai; Chi-Ming Chu; Chih-Ching Wu; Kuo-An Wu
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

8.  Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.

Authors:  Lisha Luo; Shuanglinzi Deng; Wei Tang; Xinyue Hu; Feifei Yin; Huan Ge; Jiale Tang; Zhonghua Liao; Juntao Feng; Xiaozhao Li; Biwen Mo
Journal:  J Clin Lab Anal       Date:  2022-07-12       Impact factor: 3.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.